Enda Kenny;Grayson W. Stowell;Marshall L. Grant;Per Hellstrom;Anthony Smithson;Peter Richardson;Scott Daniels;Stephanie Greene
发明人:
Peter Richardson,Enda Kenny,Per Hellstrom,Marshall L. Grant,Grayson W. Stowell,Scott Daniels,Anthony Smithson,Stephanie Greene
申请号：
US13389410
公开号：
US20120252728A1
申请日:
2010.08.05
申请国别(地区):
US
年份:
2012
代理人:
摘要：
A method of treating functional dyspepsia and/or irritable bowel syndrome in mammals in need of treatment is disclosed herein. The method comprises administering to the mammal a formulation by inhalation, wherein the formulation avoids first pass metabolism of the active ingredient. The method comprises administering a formulation by pulmonary inhalation comprising a diketopiperazine and a glucagon-like peptide (GLP-1), analog, ROSE-010.
